BRR : 3361286
Tender Brief : E-Tender For The Procurement Of Anticancer Drugs For The Year 2024-25 , Abiraterone Acetate Tab Ip 250 Mg , Afatinib Tab 30 Mg , Anastrazole Tab Ip 1Mg , Axitinib Tab 5 Mg , Azathioprine Tab Ip 50 Mg , Bendamustine Inj Ip 100Mg , Bicalutamide Tab Ip 50Mg , Bleomycin Inj Ip 15 Units , Bortezomib Inj Ip 2Mg , Cabozantinib Tab20mg , Capecitabine Tab Ip 500Mg , Ceritinib Cap 150 Mg , Cetuximab Inj 100Mg , Cyclophosphamide Tab Ip 50Mg , Cytarabine Inj Ip/Bp 100Mg , Dacarbazine Inj Ip/Usp 200Mg , Dactinomycin Inj 0.5 Mg/3Ml , Daunorubicin Inj Ip 20Mg , Denosumab Inj 120 Mg , Dexamethasone Tab Ip 8M... Read More
Tender Value
₹
Ref. Document
Contract Value
₹ 28,18,68,227.19
Submission Date
29-01-2024
Contract Date
21-11-2024
Completion Date
365 days
Participated Bidder List
22 No of Bidder(s)
| Sr No. | Bidder Name | Bid Analytics | Technical Bid | Financial Bid | AOC | Bid Value | Rank |
|---|---|---|---|---|---|---|---|
| 1 | cnet-technologies | Bid Analytics | 4,34,32,102.7 | L1 | |||
| 2 | cnet-technologies | Bid Analytics | 3,76,95,521.71 | L1 | |||
| 3 | cnet-technologies | Bid Analytics | 1,16,74,924.8 | L1 | |||
| 4 | cnet-technologies | Bid Analytics | 9,27,622.08 | L1 | |||
| 5 | cnet-technologies | Bid Analytics | 5,15,19,551.5 | L1 | |||
| 6 | cnet-technologies | Bid Analytics | 36,41,881.6 | L1 | |||
| 7 | cnet-technologies | Bid Analytics | 87,54,732 | L1 | |||
| 8 | cnet-technologies | Bid Analytics | L2 | ||||
| 9 | cnet-technologies | Bid Analytics | 63,01,157.82 | L1 | |||
| 10 | cnet-technologies | Bid Analytics | 12,81,484.96 | L1 | |||
| 11 | cnet-technologies | Bid Analytics | 6,68,714.55 | L1 | |||
| 12 | cnet-technologies | Bid Analytics | L2 | ||||
| 13 | cnet-technologies | Bid Analytics | 1,52,41,410.93 | L1 | |||
| 14 | cnet-technologies | Bid Analytics | 8,11,127.52 | L1 | |||
| 15 | cnet-technologies | Bid Analytics | 61,24,652.8 | L1 | |||
| 16 | cnet-technologies | Bid Analytics | |||||
| 17 | cnet-technologies | Bid Analytics | 2,58,405.84 | L1 | |||
| 18 | cnet-technologies | Bid Analytics | 75,55,558.5 | L1 | |||
| 19 | cnet-technologies | Bid Analytics | 4,85,51,729.45 | L1 | |||
| 20 | cnet-technologies | Bid Analytics | 16,85,214.72 | L1 | |||
| 21 | cnet-technologies | Bid Analytics | 37,00,924.64 | L1 | |||
| 22 | cnet-technologies | Bid Analytics | 3,20,41,509.08 | L1 |
Work Detail
e-tender for the procurement of anticancer drugs for the year 2024-25 , abiraterone acetate tab ip 250 mg , afatinib tab 30 mg , anastrazole tab ip 1mg , axitinib tab 5 mg , azathioprine tab ip 50 mg , bendamustine inj ip 100mg , bicalutamide tab ip 50mg , bleomycin inj ip 15 units , bortezomib inj ip 2mg , cabozantinib tab20mg , capecitabine tab ip 500mg , ceritinib cap 150 mg , cetuximab inj 100mg , cyclophosphamide tab ip 50mg , cytarabine inj ip/bp 100mg , dacarbazine inj ip/usp 200mg , dactinomycin inj 0.5 mg/3ml , daunorubicin inj ip 20mg , denosumab inj 120 mg , dexamethasone tab ip 8mg , dexamethasone tab ip 4 mg , doxorubicin (pegylated liposomal) inj 50 mg , doxorubicin liposomal inj 20mg , enzalutamide cap 80 mg , eribulin inj 0.44 mg/ml , etoposide cap ip 50mg , etoposide inj ip 100mg , exemestane tab ip 25 mg , ferric carboxymaltose inj 1gm/ 20 ml , filgrastim inj ip 300mcg , fludarabine phosphate inj ip/ usp 50 mg , fulvestrant inj 250 mg , gefitinib tab ip 250mg , ibandronate tab 50 mg , l.asparaginase inj 5000iu , lapatinib tab ip 250 mg , lenvatinib cap 4 mg , letrozole tab ip/usp 2.5mg , megestrol acetate tab ip/bp/usp 40 mg , melphalan tab ip 5mg , mercaptopurine tab ip 50 mg , mesna inj 200mg , methotrexate inj (intrathecal, preservative free) 15mg , methotrexate tab ip 2.5mg , mitomycin for inj ip/usp 10 mg , mitoxantrone infusion bp/usp 20 mg , paclitaxel nanoparticle inj 100mg , pazopanib tab 400 mg , pegfilgrastim inj 6mg , pomalidomide cap 2 mg , procarbazine hcl cap ip 50 mg , protein bound paclitaxel inj 100 mg , rasburicase inj 1.5 mg , regorafenib tab 40 mg , rucaparib tab 300 mg , sorafenib tosylate tab ip 200mg , sunitinib cap 12.5 mg , tamoxifen tab ip 20mg , tegafur +uracil cap 100 mg + 224 , thalidomide cap usp 100mg , vinblastine sulphate inj ip 10mg , zoledronic acid inj ip 4mg , bevacizumab inj 100mg , bevacizumab inj 400mg , carboplatin inj ip 150mg , carboplatin inj ip 450mg , carfilzomib inj 30mg , carfilzomib inj 60mg , cisplatin inj ip 10mg , cisplatin inj ip 50mg , cyclophosphamide inj ip 200mg , cyclophosphamide inj ip 500mg , cyclophosphamide inj ip 1 gm , dasatinib tab 20 mg , dasatinib tab 50 mg , decitabine inj 50 mg , decitabine inj 30mg , docetaxel inj ip 20mg , docetaxel inj ip 80mg , docetaxel inj ip 120 mg , doxorubicin inj (lyophilised) ip 10mg , doxorubicin inj (lyophilised) ip 50mg , epirubicin inj ip 10mg , epirubicin inj ip 50mg , erlotinib tab ip 100 mg , erlotinib tab ip 150 mg , everolimus tab 10 mg , everolimus tab 5mg , flurouracil inj ip 500mg , flurouracil inj ip 250mg , gemcitabine inj ip 200mg , gemcitabine inj ip 1gm , ifosfamide with mesna inj 1gm , ifosfamide with mesna inj 2gm , imatinib tab ip 100mg , imatinib tab ip 400mg , irinotecan inj ip 40mg , irinotecan inj ip 100mg , lenalidomide cap 10mg , lenalidomide cap 25mg , lenalidomide cap 5mg , leucovorin calcium inj ip 15mg , leucovorin calcium inj ip 50mg , leuprolide acetate inj 3.75mg , leuprolide acetate inj 11.25 mg , leuprolide acetate inj 22.5 mg , methotrexateinj ip 50mg , methotrexateinj ip 500 mg , nilotinib cap 150 mg , nilotinib cap 200 mg , octreotideinj 30 mg , octreotideinj 20mg , oxaliplatin inj ip 50mg , oxaliplatin inj ip 100mg , paclitaxel inj ip 30mg , paclitaxel inj ip with codon set 100mg , paclitaxel inj ip with codon set 260mg , pemetrexed inj ip 100mg , pemetrexed inj ip 500mg , rituximab inj 100mg , rituximab inj 500mg , temozolomide cap ip 100mg , temozolomide cap ip 250 mg , trastuzumab inj 440 mg , trastuzumab inj 150 mg , vincristine sulphate inj ip/usp 1mg , vincristine sulphate inj ip/usp 2mg
View Original Notice/Document
Result Documents
Tender Documents
Disclaimer
We takes all possible care for accurate & authentic tender information. However users are requested to refer Original source of Tender Notice / Tender Document published by Tender Issuing Agency before taking any call regarding this tender
✦ ✦ ✦
Awarded Bidder(s)
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
1
cnet-technologies
Rank : L1 (Lowest)
Bid Amount :
₹
1,00,00,000
Similar Tenders Results